Vaccinex, Inc. (VCNX)

Oncology Corporate Profile

Stock Performance


HQ Location

1895 Mount Hope Avenue
Rochester, NY 14620

Company Description

Vaccinex, Inc. is a privately held clinical-stage biotechnology company engaged in the discovery and development of human therapeutic monoclonal antibodies and other targeted biological therapies. A Vaccinex antibody product is currently in clinical trials for immunotherapy of cancer and to prevent or delay the onset of neurodegenerative Huntington’s disease.


This company does not have any commercial products

This company does not have any pipeline products


Recent News Headlines

There are no news items to display